Why the study?
The oldest-old (≥90 years) have a high burden of cognitive impairment, yet the role of visit-to-visit resting systolic BP variability in cognitive decline remains unclear.
Population
647 participants aged ≥90 years without dementia at baseline from The 90+ Study
Comparison
Low, medium, and high visit-to-visit resting systolic BP variability categories
Design
Longitudinal analysis of The 90+ Study using multi-state models
Follow-up
≥3 longitudinal BP and cognitive assessments
Answers are grounded in this paper and cite their sources.
High rSBPV should not yet guide cognitive monitoring in nonagenarians; leaves open whether variability is a modifiable target.
INTRODUCTION: The oldest-old (≥90 years) have a high burden of cognitive impairment, yet the role of blood pressure (BP) variability remains unclear. We examined whether visit-to-visit resting systolic BP variability (rSBPV) is associated with cognitive decline. METHODS: We analyzed The 90+ Study participants (n = 647) without dementia at baseline who had ≥3 longitudinal BP and cognitive assessments. rSBPV was defined as the root mean square error from within-participant regression of systolic BP on age and categorized as low, medium, or high. Multi-state models estimated transitions between normal cognition, cognitive impairment, and dementia. RESULTS: Compared with medium rSBPV, high rSBPV was associated with higher hazards of transitioning from normal cognition to cognitive impairment (hazard ratio [HR] 1.36, 95% confidence interval [CI] 1.05-1.74), from normal cognition to dementia (HR 2.90, 95% CI 1.26-6.69), and from cognitive impairment to dementia (HR 1.44, 95% CI 1.06-1.96). DISCUSSION: Higher rSBPV is associated with greater cognitive decline in older adults.
No takes yet. Share an insight, caveat, or question.
Longardner et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: